SCHULMAN AMY W

CIK 000143822614 companiesINDIANAPOLIS, IN

SEC Profile

Transactions

Companies

Filings

CIK

0001438226

Recent Transactions

50 trades

Award
Elevance Health, Inc.$ELV
Common Stock
2026-02-02+218→ 218 total
Award
FRACTYL HEALTH, INC.$GUTS
Stock Option
2025-06-11+22,500→ 22,500 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-08+775→ 11,961 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-05-08+1,558→ 1,558 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-03-13$131.21/sh+2,750→ 11,186 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-03-13−2,750→ 0 total
Purchase
FRACTYL HEALTH, INC.$GUTS
Common Stock
2025-03-13$1.17/sh+8,550→ 8,550 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-25$131.21/sh+8,500→ 16,936 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-06-25−8,500→ 2,750 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-25$240.00/sh−8,500→ 8,436 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-05-29$148.93/sh−11,516→ 8,499 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-05-29−30,000→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-05-29$149.76/sh−63→ 8,436 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-05-29$66.83/sh+30,000→ 30,136 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-05-29$148.21/sh−10,121→ 20,015 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-05-16+5,228→ 5,228 total
Award
FRACTYL HEALTH, INC.$GUTS
Stock Option
2024-02-01+45,000→ 45,000 total
Award
SQZ Biotechnologies Co
Stock Option
2023-06-14+39,875→ 39,875 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2023-05-18+3,454→ 3,454 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-02-23+136→ 136 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2023-02-23−136→ 0 total
Award
SQZ Biotechnologies Co
Stock Option
2022-06-15+20,000→ 20,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2022-05-18+5,153→ 5,153 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2022-02-23+136→ 136 total
Exercise/Conversion
SQZ Biotechnologies Co
Common Stock
2021-12-22$4.59/sh+6,581→ 214,814 total
Exercise/Conversion
SQZ Biotechnologies Co
Stock Option
2021-12-22−6,581→ 3,949 total
Exercise/Conversion
SQZ Biotechnologies Co
Stock Option
2021-12-22−7,458→ 3,072 total
Exercise/Conversion
SQZ Biotechnologies Co
Stock Option
2021-12-22−10,091→ 439 total
Exercise/Conversion
SQZ Biotechnologies Co
Common Stock
2021-12-22$4.59/sh+7,458→ 208,233 total
Exercise/Conversion
SQZ Biotechnologies Co
Common Stock
2021-12-22$2.02/sh+10,091→ 200,775 total
Purchase
SQZ Biotechnologies Co
Common Stock
2021-12-13$10.94/sh+1,850→ 1,850 total
Purchase
SQZ Biotechnologies Co
Common Stock
2021-12-13$10.88/sh+1,850→ 1,850 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-10-27+1,814→ 1,814 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-07-15+4,032→ 4,032 total
Award
SQZ Biotechnologies Co
Stock Option
2021-06-15+10,500→ 10,500 total
Purchase
Hudson Executive Investment Corp. II
Class B Common Stock
2021-04-13$0.00/sh+20,000→ 20,000 total
Conversion
SQZ Biotechnologies Co
Series D Convertible Preferred Stock
2020-11-03−348,725→ 0 total
Conversion
SQZ Biotechnologies Co
Series A Convertible Preferred Stock
2020-11-03−28,863→ 0 total
Conversion
SQZ Biotechnologies Co
Series C Convertible Preferred Stock
2020-11-03−44,120→ 0 total
Conversion
SQZ Biotechnologies Co
Series A Convertible Preferred Stock
2020-11-03−412,608→ 0 total
Conversion
SQZ Biotechnologies Co
Series D Convertible Preferred Stock
2020-11-03−24,396→ 0 total
Conversion
SQZ Biotechnologies Co
Series D Convertible Preferred Stock
2020-11-03−93,279→ 0 total
Conversion
SQZ Biotechnologies Co
Common Stock
2020-11-03+275,860→ 275,860 total
Conversion
SQZ Biotechnologies Co
Series C Convertible Preferred Stock
2020-11-03−21,087→ 0 total
Purchase
SQZ Biotechnologies Co
Common Stock
2020-11-03$16.00/sh+233,654→ 2,549,306 total
Purchase
SQZ Biotechnologies Co
Common Stock
2020-11-03$16.00/sh+16,346→ 178,340 total
Conversion
SQZ Biotechnologies Co
Series B Convertible Preferred Stock
2020-11-03−56,462→ 0 total
Conversion
SQZ Biotechnologies Co
Common Stock
2020-11-03+2,315,652→ 2,315,652 total
Conversion
SQZ Biotechnologies Co
Common Stock
2020-11-03+161,994→ 161,994 total
Conversion
SQZ Biotechnologies Co
Common Stock
2020-11-03+22,204→ 190,684 total

Companies

Recent Filings

Address

220 VIRGINIA AVENUE

INDIANAPOLIS, IN, 46204

View on SEC.gov